SynCardia Facebook SynCardia Twitter SynCardia LInkedIn SynCardia Google Plus SynCardia Youtube

SynCardia Systems, Inc.

Press Release:

3 New Centers Begin Certification Training to Implant SynCardia’s Total Artificial Heart

Tripleheader Training Features 2 Hospitals from Turkey and 1 from France

TUCSON, Ariz. – Feb. 3, 2010 – On Feb. 1 and 2, surgical teams from Turkiye Yuksek Ihtisas Hospital in Ankara, Turkey, Yeditepe University Hospital in Istanbul and University Hospital of Bordeaux in France, completed the first phase of certification training in Paris to implant the SynCardia temporary CardioWest™ Total Artificial Heart.

 

“The CE approval of the new Companion Driver System in Europe has provided us with the supply of implant drivers we need to meet demand from centers around the world who want to become certified to implant the Total Artificial Heart,” said Mary Pat Sloan, Vice President of Global Training and Customer Support. “Once stable, Total Artificial Heart patients can be switched to the European portable driver and discharged from the hospital to wait for a matching donor heart at home.”

Turkiye Yuksek Ihtisas Hospital and Yeditepe University Hospital are the 2nd and 3rd hospitals in Turkey and the 47th and 48th in the world to begin training on the SynCardia Total Artificial Heart. University Hospital of Bordeaux is the 5th hospital in France and the 49th in the world to begin certification training.

  • Turkiye Yuksek Ihtisas Hospital
    - Performs approximately 1,900 open heart surgeries each year, the
     
    2nd highest amount performed by a hospital in Turkey. It is the only
    state hospital with active cardiac transplantation and mechanical
    assist device programs.
    Attended training:     
    Assoc. Prof. Dr. Mehmet Ali Ozatik – Chief Surgeon/Anticoagulation
    Assoc. Prof. Dr. Seref Alp Kucuker – Surgeon/Anticoagulation/Drivers
  • Yeditepe University Hospital
    - Only hospital in Istanbul with a long-term mechanical assist device program. The hospital’s state-of-the-art software allows patient vital signs such as EKG, blood pressure, respiration and temperature to be transferred from the hospital bed headboards to the personal
    computers of cardiovascular surgeons.

     
    Attended training:
    Prof. Dr. Deniz Süha Küçükaksu – Chief Surgeon
    Erman Pektok, MD – Surgeon/Anticoagulation
    Halit Yerebakan, MD – Trainee in Cardiovascular Surgery/Drivers

  •  University Hospital of Bordeaux
    - Has performed more than 1,700 cardiac surgeries over the last three years.
    Attended training:
    Dr. Emmanuel Munos – Cardiac Surgeon
    Dr. Laurent Barandon – Cardiac Surgeon
    Dr. Karine Nubret – Anesthesiologist
    Dr. Alain Remy – Anesthesiologist


###

About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the temporary Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.

Follow SynCardia: Facebook | Twitter | LinkedIn | Google+

SynCardia Contact:
Janelle Drumwright, jdrumwright@syncardia.com, (520) 547-7463

Search offcanvas